Evaluation of a Partial Ban on Rx‐Rebates in Germany

Health Economics (United Kingdom) · Published 2026-05-18 · DOI 10.1002/hec.70112

Free full text

Authors (4)

Maximilian M. Gail, Georg Götz, Daniel Herold, Jan T. Schäfer

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gail, M., Götz, G., Herold, D., et al. (2026). Evaluation of a Partial Ban on Rx‐Rebates in Germany. Health Economics (United Kingdom). https://doi.org/10.1002/hec.70112

Related articles

• Long‐Term Care Insurance and Catastrophic Health Spending at the End of Life Among Older Adults: Evidence From China · Health Economics (United Kingdom) · 2026 · Same journal
• Effect of Austerity Measures on Infant Mortality: Evidence From Greece · Health Economics (United Kingdom) · 2026 · Same journal
• Further Findings on the Intergenerational Transmission of Alcohol Consumption · Health Economics (United Kingdom) · 2026 · Same journal
• The Financial and Behavioral Effects of Free Prescription Drugs: Evidence From a Policy Discontinuity in Poland · Health Economics (United Kingdom) · 2026 · Same journal
• Patient Information and Surgery Decisions: A Discrete Choice Experiment · Health Economics (United Kingdom) · 2026 · Same journal
• Gambling and Substance Use: Early Evidence From Sports Betting Laws · Health Economics (United Kingdom) · 2026 · Same journal
• Health on the Move: The Impact of Poverty Alleviation Relocation on Healthcare Utilization in China · Health Economics (United Kingdom) · 2026 · Same journal
• Threat Effects and Work Incentives: Evidence From a Danish Sick Leave Reform · Health Economics (United Kingdom) · 2026 · Same journal
• The Mental Health Impact of the COVID‐19 Pandemic on Health and Social Care Workers · Health Economics (United Kingdom) · 2026 · Same journal
• Strategic Delay and Bargaining Over Public Insurance Coverage for Drugs in Australia · Health Economics (United Kingdom) · 2026 · Same journal